Strata Mental Health Receives U.S. Grant to Train Providers for COMP360
TL/DR –
Strata Mental Health Solutions has been awarded a U.S. healthcare provider training grant by Compass Pathways to develop a provider training program for COMP360, Compass’ investigational psilocybin treatment. The Strata team, which has experience in training clinicians and providing direct care to patients receiving psychedelic treatments in regulated clinical settings, will base their training program on the approach used in the COMP360 clinical trials. In addition to training, Strata’s platform includes certification, site readiness consultation to prepare the clinic itself for treatment delivery, and ongoing clinical support to ensure responsible and effective dissemination of psychedelic treatment.
Strata Mental Health Solutions Receives U.S. Healthcare Provider Training Grant from Compass Pathways
Strata Mental Health Solutions has been awarded a U.S. healthcare provider training grant by Compass Pathways to develop the COMP360 training program. As an implementation partner for psychedelic treatments, Strata is backed by the founders who helped Compass develop the COMP360 training program for clinicians involved in Compass’ clinical trials.
Strata to Develop Healthcare Provider Training Programs
In its pivotal role, Strata will launch healthcare provider training programs for COMP360, Compass’ investigational psilocybin treatment, given FDA approval. Positive results have been witnessed from two Phase 3 trials of COMP360. The NDA submission is due for completion in Q4 2026, and the commercial roll-out of the treatment is expected by H1 2027.
Psychedelic Treatments as a Novel Approach to Psychiatric Care
Pioneering a new approach to psychiatric care, psychedelic treatments offer medication in multi-hour administration sessions with trained teams. Patients also receive additional sessions for preparation and post-treatment support. Strata will utilize its expertise in clinician training and patient care to translate the clinical trial model to real-world clinical practice for psychedelic treatments.
Training Programs for Psychedelic Treatments
Under the grant, Strata will develop training programs for the aforementioned delivery model. Based on the approach used in the COMP360 trials, Strata’s training regimen will be delivered by clinical faculty experienced in the COMP360 program. Strata’s commitment is to ensure patients receive care that aligns with the standard set in the research.
Strata’s Grant-Funded Training
The training program, a component of Strata’s implementation platform, includes structured training and certification. Beyond training, Strata’s site-readiness consultation helps prepare the clinic for psychedelic treatment programs and future treatments. “Our goal is to empower mental healthcare systems to deliver high-quality psychedelic treatments to patients in need,” stated Stephanie Knatz Peck, PhD, Co-Founder and Chief Clinical Officer at Strata.
Clinical networks can begin with a readiness consultation with Strata’s clinical team. Learn more at www.stratamentalhealth.com.
About Strata Mental Health Solutions
Strata is a leading implementation partner preparing clinical networks to deliver psychedelic treatments. Strata’s training, certification, and site-readiness programs integrate with existing clinic systems, enabling treatment teams to deliver new treatments safely from the outset. Learn more at www.stratamentalhealth.com.
Contact Info
For media inquiries, please contact at info@stratamentalhealth.com
Original source: https://www.businesswire.com/news/home/20260911394726/en/
—
Read More Health & Wellness News ; US News